Emergency Contraception Actual Use Study
Completed · Phase 3
Conditions studied: Emergency Contraception
In brief
This is a non-comparative case series study to assess the ability of females 11-16 years of age, inclusive, who are requesting emergency contraception (EC) to use the study product, DR-104 (Plan B® 1.5), appropriately and safely without provider counseling.
Key facts
- Study ID
- NCT00777556
- Run by
- Duramed Research
- People needed
- 343
- Starts
- 2008-10-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2012-10-18
Who can join
Age: 11 and older, up to 16. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female and 11-16 years of age, inclusive
- Subject must be requesting emergency contraception for her own use (not for use by another person) and for current (not future) use
- Subject can read and understand English, according to her own judgment
- Others as dictated by FDA-approved protocol
Where it is running
- Duramed Research Investigational Site — San Francisco, California, United States
- Duramed Research Investigational Site — Atlanta, Georgia, United States
- Duramed Research Investigational Site — Minneapolis, Minnesota, United States
- Duramed Research Investigational Site — Philadelphia, Pennsylvania, United States
- Teva Investigational Site — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.